The effect of C3 depletion on the multiple pathophysiological changes produced by a lethal dose of Serratia marcescens lipopolysaccharide (LPS) was evaluated. The injection of this LPS into rabbits resulted in biphasic hypotensive changes and thrombocytopenia. These changes were characterized by an acute, transient decrease occurring within minutes after injection followed by a second more gradual decrease beginning 30 to 60 min post-LPS. Prior depletion of C3, with the anticomplementary protein from cobra venom (CoF), did not alter the extent of either the gradual hypotensive and platelet changes or the coagulative and metabolic changes when normal and C3-depleted rabbits were compared. Importantly, the lethal effects ofS. marcescens LPS were not reduced by prior depletion of C3. Only the immediate, reversible thrombocytopenia and hypotension were abrogated by C3 depletion.
The effect of C3 depletion on the multiple pathophysiological changes produced by a lethal dose of Serratia marcescens lipopolysaccharide (LPS) was evaluated. The injection of this LPS into rabbits resulted in biphasic hypotensive changes and thrombocytopenia. These changes were characterized by an acute, transient decrease occurring within minutes after injection followed by a second more gradual decrease beginning 30 to 60 min post-LPS. Prior depletion of C3, with the anticomplementary protein from cobra venom (CoF), did not alter the extent of either the gradual hypotensive and platelet changes or the coagulative and metabolic changes when normal and C3-depleted rabbits were compared. Importantly, the lethal effects ofS. marcescens LPS were not reduced by prior depletion of C3. Only the immediate, reversible thrombocytopenia and hypotension were abrogated by C3 depletion.
Previous studies from this laboratory have indicated that either prior depletion of C3 and terminal complement components or the absence of C6 in rabbits failed to alter the hypotension or disseminated intravascular coagudation (DIC) induced by a single injection of bacterial lipopolysaccharide (LPS) (18, 19) . In these studies we presented evidence suggesting that C3 was required only in the acute reversible thrombocytopenia resulting from the injection of certain LPS preparations. Reports from other laboratories have also demonstrated a role for C3 in the acute, at least partially reversible, changes resulting from LPS injection. These data include the demonstration that C3 depletion markedly reduces both the immediate LPSinduced hypotension in dogs (7, 8) as well as the acute thrombocytopenia observed in dogs and rabbits (5, 8) .
However, some experimental observations have suggested that, in addition to a role of complement in the acute LPS-induced changes, the complement system may mediate some of the secondary pathophysiological changes occurring in lethal LPS-induced shock. These observations include the demonstration that C3 depletion abrogates LPS-induced DIC and lethality in dogs (8) and rabbits (5) and that C3 depletion abrogates the second phase of hypotension in dogs (8) . Since our previous studies were performed with sublethal doses of LPS, the question arises whether the pathogenic ef- fects of sublethal and lethal doses of LPS occur by different mechanisms. In fact, over ten years ago Gilbert and Braude (9) suggested that the mechanism of death from endotoxin may differ for doses of LPS below and above a 50% lethal dose. Therefore, the role of complement in the acute reversible changes and the secondary injury resulting from the injection of a lethal dose of LPS requires further clarification.
The experiments described here were undertaken to investigate the role of C3 in both the acute as well as the secondary pathophysiological changes observed in lethal LPS-induced shock and DIC. To do this we will utilize rabbits with normal complement levels and rabbits depleted of C3 and terminal complement component with the anticomplementary protein isolated from cobra venom (2 Measurement of LPS-induced injury. Surgical procedures and blood pressure measurements were performed as described previously (18) .
Arterial blood samples were removed from a femoral artery catheter immediately prior to LPS injection, 5, 30, or 60, 180, and 300 min after and anticoagulated with 0.38% sodium citrate (final concentration). Peripheral blood cell counts were performed by standard cell counting methods. Platelet-free plasma for coagulation assays was separated by centrifugation and stored at -70°C. Serum was prepared from whole blood and allowed to clot in glass tubes at 37°C. Arterial blood samples were also collected into 1-ml plastic syringes containing 2 U of heparin, with the needle tip blocked to prevent gas exchange, and the syringes were maintained at 4°C. Measurements of pH, pO2, and pCO2 were performed with an Instrumentation Laboratory, Inc. pH-blood gas analyzer within 30 min after the blood was removed. Serum 50% hemolytic complement (CH5o) levels and plasma C3 concentrations were determined as described previously (18) .
The concentration of clotting components was assayed by adding 0.05 ml of a 1:20 dilution of test plasma to 0.05 ml of human plasma deficient in factor XII (generously given by Gunda Hiatt), or factors XI, VIII, and VII (obtained from George King, Salem, N.H.) (10) . Units of clotting activity were obtained from a curve of pooled normal human plasma. The values of each experimental test were then corrected for changes in plasma protein concentration associated with the development of shock by obtaining the total protein concentration of the plasma at each time point.
In some experiments changes in circulating platelets were determined by the injection of 5"Cr-platelets 18 to 24 h before the beginning of the experiment. 5"Crplatelets were prepared and utilized as described previously (19) . The maximum amount of blood removed from an experimental animal during the 6-h experiment was 12 ml.
Depletion of C3. Cobra venom factor (CoF) was purified by diethylaminoethyl-Sephadex A50 chromatography and G-200 molecular exclusion chromatography (2) . Rabbits were depleted of C3 with intraperitoneal injections of CoF as described previously (18) . In all experiments at the time of LPS injection, the plasma C3 concentration was always less than 10% of the pre-CoF concentration.
Gross RESULTS Hemodynamic changes in normal and C3-depleted rabbits. We first sought to characterize the kinetics and extent of the blood pressure changes resulting from an intravenous bolus injection of 5 mg of S. marcescens LPS into rabbits with normal complement levels. As shown in Fig. 1 , the blood pressure decrease was characterized by a biphasic hypotensive change. Within 1 to 2 min after injection, the arterial blood pressure decreased rapidly to about 50% of the preinjection level and remained at this level for approximately 3 to 6 min. After this acute change, the blood pressure returned to 80 to 90% of the pre-LPS level 30 min after injection. During the remaining 4.5 h of the experiment the mean arterial blood pressure gradually decreased again to approximately 60% of the pre-LPS value.
To determine if the presence of C3 was required for either the acute, transient, or more gradual LPS-induced hypotensive changes, six rabbits were depleted of C3 prior to LPS injection by multiple intraperitoneal injections of CoF. At the time of LPS injection, circulating C3 levels were less than 10% of the pre-CoF value. In marked contrast to the results described above, the injection of 5 mg of S. marcescens LPS into the C3-depleted rabbits did not produce the acute transient blood pressure decrease. However, the blood pressure was observed to decrease gradually beginning 30 Effect of LPS on serum hemolytic complement and C3 levels. Bacterial LPS can activate both the classical as well as the alternative pathways of complement (15) . Therefore, to determine the anticomplementary activity of S. marcescens LPS in vivo, we compared CH50 and C3 levels immediately before and 30 and 180 min after LPS injection (Fig. 2) . CHso levels decreased approximately 30% and remained depressed for at least 3 h after LPS injection. In addition, the concentration of C3 as measured immunologically also decreased 30% and remained depressed for at least 3 h. We determined that the plasma concentration of immunoglobulin G and albumin did not change during the experiment. Therefore, the decrease in C3 levels and CH50 reflects specific consumption of these proteins by LPS Considering the consumption of complement by the injection of LPS, it was of interest to examine the effects of LPS injection on circulating 56Cr-platelets in rabbits with normal complement levels and rabbits depleted of C3 by prior administration of CoF. These studies were performed to evaluate the role of C3 in LPS-induced thrombocytopenia and to determine how changes in platelet levels correlate with the immediate and prolonged hemodynamic changes and the development of DIC (see below) resulting from LPS injection.
The injection of 5 mg of S. marcescens LPS into rabbits with normal complement levels prior to injection produced a rapid decrease in the total number of circulating platelets. Within 5 min, 90% of the platelets present in the blood prior to LPS injection disappeared from the circulation. During the remainder of the experiment the platelet changes were characterized by a gradual return to the circulation to 40% of the pre-LPS platelet levels at 180 min post-LPS followed by a secondary gradual fall between 180 and 300 min.
CoF pretreatment abrogated the acute decrease in circulating platelets but did not prevent the platelets from gradually dropping to approximately 50% of the pre-LPS level during the 5-h experiment. The rate of disappearance of 51Cr-platelets between 180 and 300 min after (Fig. 3) .
Coagulative changes induced by LPS. The occurrence of DIC was evaluated by microscopic examination of various tissues for the presence of fibrin and by comparing the levels of various coagulation factors in plasma before and at different times after LPS injection. Gross and microscopic observations were performed in normal and 03-depleted rabbits. Quantitatively similar changes occurred in normal and CoF-treated rabbits injected with S. marcescens LPS. In both normal as well as C3-depleted rabbits, the lungs were reddened and occasionally ecchymoses were noted in both lungs and along the serosal surface of the large and small bowel. In some rabbits, yellowish flecks of 1 to 2 mm, representing zones ofcoagulative necrosis, were observed on the surface of the liver with penetration occurring several millimeters into the cut surface. The kidneys showed early evidence of coagulative necrosis, but otherwise appeared normaL. Microscopically, moderate to marked numbers of fibrin thrombi were seen in all rabbits injected with LPS. The distribution and extent of thrombi is shown in Table 3 . No thrombi were observed in saline controls.
The plasma levels of clotting factors XII, XI, VIII, and VII at various times after aministration of LPS are given in Fig. 4 . The values are corrected for minor changes in the concentration of plasma proteins over the 300-min period. As noted, a decreased concentration of factors XI, VIII, and VII was observed over the given time period. A somewhat greater fall was observed in factors XI and VIII in the CoF-treated rabbits at 180, but not at 300, min. Factor XII levels remained near normal throughout in both normal and CoF-treated rabbits. DISCUSSION The injection of a lethal dose of S. marcescens 4 . Changes in coagulation factors produced by the injection of 5 mg of S. marcescens LPS in normal (Ol) and C3-depleted rabbits (s). The range of changes in coagulation factors measured in control animals is shown in the stippled area. A group of six rabbits injected with saline was employed for. this group (FE).
LPS results in multiple pathophysiological changes characteristic of LPS-induced shock including hypotension, thrombocytopenia, decreased blood pH, and severe DIC. Certain of these changes, most notably the hypotension and thrombocytopenia, occur with two kinetically distinct phases. These biphasic changes are characterized by an immediate, at least partially reversible, decrease occunring within minutes after LPS injection. Secondary decreases in blood pressure, platelet numbers, and the development of a metabolic acidosis and DIC follow the acute LPS-induced changes.
We have examined the role of C3 in the pathogenesis of S. marcescens LPS-induced shock and DIC. To do this we studied two groups of rabbits, namely, rabbits with normal complement levels and rabbits depleted of C3 prior to LPS injection. The data described here demonstrate that C3 depletion does not prevent either the irreversible pathophysiological changes or the lethality resulting from the injection of 5 mg of a highly anticomplementary preparation of S. marcescens LPS. Prior depletion of C3 did, however, abrogate the endotoxin-induced, acute, transient hypotension and thrombocytopenia.
The rapid injection of a lethal dose of S. marcescens LPS results in a specific reduction of total serum hemolytic complement and plasma C3 detectable within 30 min of LPS injection. Biologically active products resulting from LPS-induced complement activation appear to mediate, in part, the C3-dependent transient thrombocytopenia and hypotension described in this report. The transient nature of these changes may result from the production of short-lived mediators such as the anaphylatoxins. The early platelet drop results in a significant portion of total circulating platelets being either irreversibly sequestered or lysed. Several possible mechanisms for this change must be considered including: (i) an immune adherence reaction involving platelets 03b bound to their surface (12); (ii) a lytic reaction in which the terminal complement components lyse the platelet membrane (14); (iii) anaphylatoxin-mediated release of other factors that could affect platelet behavior, e.g., platelet activating factor from basophils (3) ; and (iv) LPSinduced release of adenine 5'-diphosphate from cells by direct or indirect mechanisms (3) .
The abrogation of the LPS-induced acute hypotensive response in dogs by prior C3 depletion has also been described by From et al. (7) and Garner and his co-workers (8) . The kinetics of the transient, C3-dependent hypotension induced by S. marcescens LPS, are similar to the hypotensive changes resulting from the rapid intravenous injection of CoF observed in dogs and rabbits (7, 17 The demonstration of two kinetically distinct phases ofLPS-induced hypotension in the rabbit has previously been reported by Heiffer et al. (11) . These authors demonstrated a similar time course in hypotension to that reported here following the injection of an Escherichia coli LPS (Difco) in the rabbit. The biphasic hypotensive response to LPS appears to be dependent upon the type of LPS used. That is, 5 mg of the Boivin preparation (4) of S. marcescens LPS used here produces a biphasic response, whereas up to 2.5 times as much of a Westphal preparation (20) of S. marcescens does not induce the rapid hypotensive changes but does produce identical secondary blood pressure decreases (R. Ulevitch, unpublished data). It is of interest to note that the Boivin preparation of S. marcescens LPS is highly anticomplementary and, on a weight basis, is at least two orders of magnitude more potent than the Westphal preparation of S. marcescens and a preparation of LPS from E. coli 0111:B4 (D. Morrison, personal communication). The basis of these differences is currently under study in this laboratory.
We have been unable to obtain experimental evidence implicating C3-dependent reactions in the pathogenesis of the secondary LPS-induced changes of lethal hypotensive shock. The irreversible pathophysiological changes characteristic of lethal endotoxin shock and DIC are indistinguishable when rabbits with normal complement levels and C3-depleted rabbits are compared. The present findings are consistent with our previous studies in which the effect of C3 depletion on hemodynamic, hematological, and coagulative changes induced by sublethal doses of gram-negative bacterial LPS was examined (18, 19) . These earlier studies, employing LPS isolated from three different gram-negative bacilli, demonstrated that C3 depletion did not alter the kinetics or extent of the hypotension, the secondary platelet changes, or the development of DIC in the rabbit. Kitzmiller et al. (13) reported that prior C3 depletion with CoF of felines did not prevent the lethal effects of a Boivin preparation of E. coli 011l:B4 endotoxin.
The later course of endotoxin shock, e.g. the hypotension, thrombocytopenia, and decreased 210 ULEVITCH AND COCHRANE blood pH, also was not altered by C3 depletion.
Pretreatment of rabbits with CoF failed to prevent the fall in levels of clotting factors XI, Vm, and VII of the intrinsic and extrinsic clotting systems. If anything, greater loss of the activities of factors VIII and XI appeared to occur after 180 min of LPS injection in the CoFtreated rabbits. Histologically graded disseminated intravascular coagulation was comparable in the two groups of rabbits. These data suggest that the action of C3 and terminal components are not required for the generation of coagulation. The pattern of a fall in factors XI, VIII, and VII despite normal levels of factor XII is of interest and at least superficially, paradoxical. The question is currently being investigated.
The data presented here suggest that the kinetically distinct phases of LPS-induced hypotension and thrombocytopenia are mediated by distinct biochemical mechanisms, namely complement-dependent and -independent reactions. These distinct phases of LPS-induced changes may result from the partitioning of the injected LPS into multiple forms with different biological effects. The partitioning may result from interactions of LPS with humoral factors that are responsible for LPS inactivation and clearance. Specifically, several studies have indicated that LPS interacts with lipid or lipoprotein components of plasma and that these interactions lead to inactivation of the LPS (1, 6, 16) .
We envision the partitioning of LPS to include the following species. (i) LPS which, prior to inactivation or clearance, interacts with plasma protein systems such as complement or the Hageman factor activated pathways. These interactions could result in the production of biologically active, short-lived mediators. (ii) LPS which escapes the inactivation and clearance mechaisms and is bound to critical targets. These targets might include peripheral blood cells, endothelial cells or other tissue-bound cells. Interaction with these targets could result in the production of procoagulant or vasoactive substances and thus lead to injury. (iii) LPS that is inactivated by humoral factors, circulating as biologically inactive LPS and ultimately removed by cells of the reticuloendothelial system. (iv) LPS which is directly removed by phagocytic cells of the reticuloendothelial system. Thus, we propose that LPS, which escapes inactivation and clearance and is bound to certain critical targets, is responsible for producing the biochemical changes leading to hypotensive shock, DIC, and death.
